50 related articles for article (PubMed ID: 22399602)
1. Interleukin-21 increases direct cytotoxicity and IFN-γ production of ex vivo expanded NK cells towards breast cancer cells.
Park YK; Shin DJ; Cho D; Kim SK; Lee JJ; Shin MG; Ryang DW; Lee JS; Park MH; Yoon JH; Jegal YJ
Anticancer Res; 2012 Mar; 32(3):839-46. PubMed ID: 22399602
[TBL] [Abstract][Full Text] [Related]
2. Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours.
Shenouda MM; Gillgrass A; Nham T; Hogg R; Lee AJ; Chew MV; Shafaei M; Aarts C; Lee DA; Hassell J; Bane A; Dhesy-Thind S; Ashkar AA
Breast Cancer Res; 2017 Jul; 19(1):76. PubMed ID: 28668076
[TBL] [Abstract][Full Text] [Related]
3. Expansion of cytotoxic natural killer cells in multiple myeloma patients using K562 cells expressing OX40 ligand and membrane-bound IL-18 and IL-21.
Thangaraj JL; Phan MT; Kweon S; Kim J; Lee JM; Hwang I; Park J; Doh J; Lee SH; Vo MC; Chu TH; Song GY; Ahn SY; Jung SH; Kim HJ; Cho D; Lee JJ
Cancer Immunol Immunother; 2022 Mar; 71(3):613-625. PubMed ID: 34282497
[TBL] [Abstract][Full Text] [Related]
4. Effect of interleukins (IL-2, IL-15, IL-18) on receptors activation and cytotoxic activity of natural killer cells in breast cancer cell.
Widowati W; Jasaputra DK; Sumitro SB; Widodo MA; Mozef T; Rizal R; Kusuma HSW; Laksmitawati DR; Murti H; Bachtiar I; Faried A
Afr Health Sci; 2020 Jun; 20(2):822-832. PubMed ID: 33163049
[TBL] [Abstract][Full Text] [Related]
5. Squamous cell carcinoma cells differentially stimulate NK cell effector functions: the role of IL-18.
Moore MB; Kurago ZB; Fullenkamp CA; Lutz CT
Cancer Immunol Immunother; 2003 Feb; 52(2):107-15. PubMed ID: 12594574
[TBL] [Abstract][Full Text] [Related]
6. Interferon-Gamma Secretion Is Significantly Decreased in Stage III Breast Cancer Patients.
Yi JI; Schneider J; Lim ST; Park B; Suh YJ
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674146
[TBL] [Abstract][Full Text] [Related]
7. Gene expression analysis of ex vivo expanded and freshly isolated NK cells from cancer patients.
Park KU; Jin P; Sabatino M; Feng J; Civini S; Khuu H; Berg M; Childs R; Stroncek D
J Immunother; 2010; 33(9):945-55. PubMed ID: 20948442
[TBL] [Abstract][Full Text] [Related]
8. Impaired local natural killer cell activity in human colorectal carcinomas.
Aparicio-Pagés NM; Verspaget HW; Peña SA; Lamers CB
Cancer Immunol Immunother; 1989; 28(4):301-4. PubMed ID: 2495180
[TBL] [Abstract][Full Text] [Related]
9. Complementary activation of peripheral natural killer cell immunity in nasopharyngeal carcinoma.
Zheng Y; Cao KY; Ng SP; Chua DT; Sham JS; Kwong DL; Ng MH; Lu L; Zheng BJ
Cancer Sci; 2006 Sep; 97(9):912-9. PubMed ID: 16805822
[TBL] [Abstract][Full Text] [Related]
10. Optimization of
Peighambarzadeh F; Najafalizadeh A; Esmaeil N; Rezaei A; Ashrafi F; Ganjalikhani Hakemi M
Avicenna J Med Biotechnol; 2020; 12(1):17-23. PubMed ID: 32153734
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of thioredoxin-1 in activated human NK cells confers increased tolerance to oxidative stress.
Mimura K; Kua LF; Shimasaki N; Shiraishi K; Nakajima S; Siang LK; Shabbir A; So J; Yong WP; Kono K
Cancer Immunol Immunother; 2017 May; 66(5):605-613. PubMed ID: 28224212
[TBL] [Abstract][Full Text] [Related]
12. Metabolic changes of Interleukin-12/15/18-stimulated human NK cells.
Terrén I; Orrantia A; Mosteiro A; Vitallé J; Zenarruzabeitia O; Borrego F
Sci Rep; 2021 Mar; 11(1):6472. PubMed ID: 33742092
[TBL] [Abstract][Full Text] [Related]
13. Role of beta-(1→3)(1→6)-D-glucan derived from yeast on natural killer (NK) cells and breast cancer cell lines in 2D and 3D cultures.
Boulifa A; Raftery MJ; Franzén AS; Radecke C; Stintzing S; Blohmer JU; Pecher G
BMC Cancer; 2024 Mar; 24(1):339. PubMed ID: 38486205
[TBL] [Abstract][Full Text] [Related]
14. Defective NK cell expansion, cytotoxicity, and lack of ability to differentiate tumors from a pancreatic cancer patient in a long term follow-up: implication in the progression of cancer.
Kaur K; Ko MW; Chen F; Jewett A
Cancer Immunol Immunother; 2022 May; 71(5):1033-1047. PubMed ID: 34559307
[TBL] [Abstract][Full Text] [Related]
15. Effect of exposure to interleukin-21 at various time points on human natural killer cell culture.
Lim DP; Jang YY; Kim S; Koh SS; Lee JJ; Kim JS; Thi Phan MT; Shin DJ; Shin MG; Lee SH; Yoon M; Kim SK; Yoon JH; Park MH; Cho D
Cytotherapy; 2014 Oct; 16(10):1419-30. PubMed ID: 24950680
[TBL] [Abstract][Full Text] [Related]
16. Ex vivo expansion of natural killer cells using cryopreserved irradiated feeder cells.
Baek HJ; Kim JS; Yoon M; Lee JJ; Shin MG; Ryang DW; Kook H; Kim SK; Cho D
Anticancer Res; 2013 May; 33(5):2011-9. PubMed ID: 23645750
[TBL] [Abstract][Full Text] [Related]
17. Expansion of NK Cells Using Genetically Engineered K562 Feeder Cells.
Phan MT; Lee SH; Kim SK; Cho D
Methods Mol Biol; 2016; 1441():167-74. PubMed ID: 27177665
[TBL] [Abstract][Full Text] [Related]
18. Effects of ADAM10 and ADAM17 Inhibitors on Natural Killer Cell Expansion and Antibody-dependent Cellular Cytotoxicity Against Breast Cancer Cells
Pham DH; Kim JS; Kim SK; Shin DJ; Uong NT; Hyun H; Yoon MS; Kang SJ; Ryu YJ; Cho JS; Yoon JH; Lee JS; Cho D; Lee SH; Park MH
Anticancer Res; 2017 Oct; 37(10):5507-5513. PubMed ID: 28982863
[TBL] [Abstract][Full Text] [Related]
19. HLA-DR Expression in Natural Killer Cells Marks Distinct Functional States, Depending on Cell Differentiation Stage.
Kust SA; Ustiuzhanina MO; Streltsova MA; Shelyakin PV; Kryukov MA; Lutsenko GV; Sudarikova AV; Merzlyak EM; Britanova OV; Sapozhnikov AM; Kovalenko EI
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731828
[TBL] [Abstract][Full Text] [Related]
20. Suppression of NK Cell Activation by JAK3 Inhibition: Implication in the Treatment of Autoimmune Diseases.
Wu WC; Shiu C; Tong TK; Leung SO; Hui CW
J Immunol Res; 2023; 2023():8924603. PubMed ID: 38106519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
